Document is current
Any future updates will be listed below
-
Authors
Scholte, Niels T. B.
Clephas, Pascal R. D.
Boersma, Eric
Gürgöze, Muhammed T.
Ronner, Eelko
Feyz, Lida
de Boer, Rudolf A.
van der Boon, Robert M. A.
Brugts, Jasper J.
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (628.011.214)
- License Information
-
More Information
Article History
Received: 8 May 2025
Accepted: 28 January 2026
First Online: 10 February 2026
Competing interests
: The institution of the authors Boer has received research grants and/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, NovoNordisk, and Roche. R.A.d.B.: has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, NovoNordisk, Roche, and Zoll and received travel support from Abbott and NovoNordisk. R.M.A.v.d.B.: reports an independent research grant paid to the Institute from Abbott for IIS and has had speaker engagement in the past 5 years with Abbott, AstraZeneca, and Novartis. J.J.B:. reports an independent research grant paid to the Institute from Abbott for IIS and has had speaker engagement or advisory boards in the past 5 years with: AstraZeneca, Abbott, Boehringer-Ingelheim, Bayer, Daiichi Sankyo, Novartis and Vifor. All other authors declared to have no conflict of interest.
